L Cabel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

L Cabel

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

ESMO Open|May 13, 2021

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life databaseM Carausu, M Carton, A Darlix, et al.

ESMO Open|November 26, 2025

PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohortF Cherifi, L Cabel, C Bousrih, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2025

Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancerA Mamann, Y Pradat, F C Bidard, et al.

British Journal of Cancer|June 25, 2024

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancerF Poumeaud, M Morisseau, L Cabel, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

ESMO Open|May 13, 2021

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life databaseM Carausu, M Carton, A Darlix, et al.

ESMO Open|November 26, 2025

PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohortF Cherifi, L Cabel, C Bousrih, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2025

Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancerA Mamann, Y Pradat, F C Bidard, et al.

British Journal of Cancer|June 25, 2024

Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancerF Poumeaud, M Morisseau, L Cabel, et al.

Pageof 2